TENNOR THERAP-B（06872）
Dano Pharmaceutical is a biotechnology company approaching the commercialization stage, focusing on the discovery, development and commercialization of differentiated innovative pharmaceutical products to address unmet clinical needs in the fields of bacterial infections and bacterial metabolism‑related diseases.
Progress
Subscription Opens
May 16, 2026, 07:00 AM UTC+0
Subscription Closes
May 18, 2026, 07:00 AM UTC+0
Allotment Results
May 19, 2026 UTC+0
Listed
May 21, 2026 UTC+0
Details
Offer Price
75.7HKD
Shares per Lot
--
Minimum Subscription Amount
--HKD
Market Cap
--
Shares Issued
--
Clawback Mechanism
--
Public Offer Ratio
--
Industry Sector
Biotechnology
Greenshoe
--
Sponsor
--
Prospectus
Prospectus.pdfUse of Funds
Name
Subscribed Shares/Proportion
Unlock Date
No data
Underwriters 0 in total
No data